School of Public Health, Chinese Academy of Medical Sciences &Peking Union Medical College, 5 DongDanSanTiao, Dongcheng District, Beijing, China.
Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
BMC Public Health. 2019 Nov 21;19(1):1546. doi: 10.1186/s12889-019-7903-x.
While the HPV vaccines have been approved by the US FDA since 2006, in recent years an increasing number of women are living with cervical cancer globally. Among them, Chinese women have a higher cervical cancer incidence and mortality rate than the global average, with mortality rates being almost twice the global average. However, the current approach of HPV vaccination in China is not satisfactory given the high disease burden of cervical cancer. The current study is a randomized controlled trial designed to identify the barriers and facilitators of HPV vaccination among Chinese female students. This study will also test a health intervention measure via a popular form of new media in order to improve the HPV vaccine uptake under the framework of Information-Motivation-Behavioral skill Model (IMB).
This investigation is a multicenter, school-based, prospective, randomized, parallel group, double-blind, blank-controlled trial involving a 7-day education intervention with a further 6-month follow-up. We will enroll at least 3360 participants older than 18 years. The enrolled participants will be randomly divided into two groups (1:1 ratio). The intervention group will be offered a 7-day mobile health education, and participants in both groups will fill out 4 questionnaires at the baseline, 1 month, 3 months and 6 months after the intervention. The primary outcome is the difference in HPV vaccination or reservation for the HPV vaccine between the intervention and control groups. Secondary outcomes will include the comparison of (1) knowledge, attitudes, motivation, beliefs and behavioral skill about HPV and cervical cancer prevention, and (2) the willingness to uptake HPV vaccination.
This study will examine the theory-based intervention in improving HPV vaccination among Chinese female college students. We will conduct the randomized controlled trial to provide scientific evidence on the potential effect of the IMB theory-based intervention. Findings from this study will contribute to a growing research field which assesses the effectiveness of mobile-based, school-targeted and theoretically guided interventions for promoting HPV vaccination in adolescents.
Chinese Clinical Trial Registry (ChiCTR), ChiCTR1900025476; Registered on 27 August 2019.
自 2006 年以来,HPV 疫苗已获得美国 FDA 批准,但近年来,全球范围内越来越多的女性患有宫颈癌。其中,中国女性的宫颈癌发病率和死亡率均高于全球平均水平,死亡率几乎是全球平均水平的两倍。然而,鉴于宫颈癌的疾病负担较高,目前中国的 HPV 疫苗接种方式并不令人满意。本研究是一项随机对照试验,旨在确定中国女学生 HPV 疫苗接种的障碍和促进因素。本研究还将通过一种流行的新媒体形式测试一种健康干预措施,以便在信息-动机-行为技能模型(IMB)框架下提高 HPV 疫苗的接种率。
本研究是一项多中心、以学校为基础、前瞻性、随机、平行组、双盲、空白对照试验,包括为期 7 天的教育干预和进一步的 6 个月随访。我们将招募至少 3360 名 18 岁以上的参与者。招募的参与者将被随机分为两组(1:1 比例)。干预组将接受为期 7 天的移动健康教育,两组参与者将在干预前、干预后 1 个月、3 个月和 6 个月填写 4 份问卷。主要结局是干预组与对照组之间 HPV 疫苗接种或 HPV 疫苗预约的差异。次要结局将包括以下两方面的比较:(1)HPV 和宫颈癌预防的知识、态度、动机、信念和行为技能;(2)接种 HPV 疫苗的意愿。
本研究将检验基于理论的干预措施在提高中国女大学生 HPV 疫苗接种率方面的效果。我们将开展随机对照试验,为基于 IMB 理论的干预措施的潜在效果提供科学证据。这项研究的结果将有助于一个不断发展的研究领域,该领域评估基于移动、针对学校和基于理论的干预措施在促进青少年 HPV 疫苗接种方面的有效性。
中国临床试验注册中心(ChiCTR),ChiCTR1900025476;注册于 2019 年 8 月 27 日。